Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hims & Hers Health Inc.

25.35
-0.4900-1.90%
Post-market: 25.500.1500+0.59%16:51 EDT
Volume:21.35M
Turnover:551.08M
Market Cap:5.63B
PE:47.63
High:26.70
Open:26.49
Low:25.13
Close:25.84
Loading ...

Stock Track | Hims & Hers Plummets 25% as Weight Loss Drug Business Faces Hurdles

Stock Track
·
25 Feb

Heard on the Street: Why Hims & Hers Stock Has Further to Fall -- WSJ

Dow Jones
·
25 Feb

Hims & Hers Stumbles as GLP-1 Compounding Ends. Lilly Presses the Advantage. -- Barrons.com

Dow Jones
·
25 Feb

Hims & Hers Shares Down 19.9% After Co Warns It May Stop Selling Compounded Weight-Loss Drugs

THOMSON REUTERS
·
25 Feb

Novo shares rise as HIMS halt sales of some obesity drugs

Investing.com
·
25 Feb

Novo Nordisk's stock is rallying as Hims & Hers' stock falters. An Ozempic alternative won't be available for long.

Dow Jones
·
25 Feb

Hims & Hers Health Is Maintained at Buy by Needham

Dow Jones
·
25 Feb

Hims & Hers shares drop on doubts over weight-loss business forecast

Reuters
·
25 Feb

BUZZ-U.S. STOCKS ON THE MOVE- Zoom Communications, Home Depot, Civitas Resources

Reuters
·
25 Feb

Social Buzz: Wallstreetbets Stocks Mostly Lower Premarket Tuesday; Hims & Hers Health, Intuitive Machines to Open Lower

MT Newswires Live
·
25 Feb

BUZZ-Hims & Hers slides on warning it may stop compounded version of Wegovy

Reuters
·
25 Feb

Analysts Conflicted on These Healthcare Names: Hims & Hers Health (HIMS) and Novo Nordisk (NVO)

TIPRANKS
·
25 Feb

Hims & Hers Health Inc : Leerink Partners Raises Target Price to $40 From $24

THOMSON REUTERS
·
25 Feb

U.S. Stocks to Watch: Super Micro, Palantir, Nvidia, Hims & Hers, Strategy, Home Depot, and More

Dow Jones
·
25 Feb

Novo Nordisk Shares Jumped 3.7% On HIMS To Stop Selling Weight-Loss Drugs

Tiger Newspress
·
25 Feb

Stock Track | Hims & Hers Stock Plunges 17.77% in Pre-Market as Weight Loss Drug Business Faces Uncertainty

Stock Track
·
25 Feb

Hims & Hers Shares Drop 17.3% Premarket After Co Warns It May Stop Selling Compounded Weight-Loss Drugs

THOMSON REUTERS
·
25 Feb

Hims & Hers Health Inc : Piper Sandler Raises Target Price to $35 From $24

THOMSON REUTERS
·
25 Feb

Hims & Hers (HIMS) Sees 69% Revenue Increase Despite GLP-1 Uncertainties

TIPRANKS
·
25 Feb

24H|Medical AI Stocks Fall; Hims & Hers Health Drops 19%; Tempus AI Tumbles 14%; Palantir and Zoom Decline 3%

Tiger Newspress
·
25 Feb